Pallavi Nahata, n/a

Cerus Corporation

Poster(s):

• (P-CB-2) Amotosalen/UVA Treatment of Platelet and Plasma Components using the INTERCEPT Blood Systems to inactivate WHO Reference Bacterial Strains
  Saturday, October 14, 2023